Familial Leiomyoma
Familial leiomyoma, also known as hereditary leiomyomatosis and renal cell cancer (HLRCC), is a genetic disorder characterized by a mutation in the FH gene. This mutation disrupts the Krebs cycle, which is responsible for converting carbohydrates and fats from the diet into energy. As a result, individuals with this condition are unable to utilize oxygen efficiently, creating an environment that promotes the growth of leiomyomas and renal cell cancer.
One of the primary symptoms of familial leiomyoma is the progressive increase in the size and number of piloleiomyomas, a type of smooth muscle tumor. Additionally, women with this condition may develop larger uterine fibroids at a younger age compared to those without the disorder.
Benign Metastatic Leiomyoma
Benign metastatic leiomyomas (BMLs) are growths that primarily occur in the lungs but can also be found in uncommon areas such as the heart, lymph nodes, and bones. Initially, these growths develop as uterine fibroids in women before spreading to other parts of the body. While BMLs typically do not present any noticeable symptoms, they can pose a significant risk depending on their size and location. It is not uncommon for doctors to stumble upon these growths incidentally during routine examinations. However, despite their benign nature, certain tumors may possess estrogen and progesterone receptors, making them susceptible to hormone treatments for effective control.